Assessment of feasibility and economic efficiency of the practical implementation of the project of a new domestic production of antitumor drugs in various dosage forms

   Oncological diseases are among the most common in Russia and in the world, and their treatment requires adequate drug provision. At the same time, the Russian market as a whole, as well as the St. Petersburg market, is dominated by imported antitumor drugs in value terms, the share of which exceeds 76.1 %. Although more domestic drugs are purchased in packages, in some cases their share is insignificant, and sometimes equals zero. In this regard, it is relevant to organize the production of antitumor drugs, which are characterized by small volumes of Russian manufacturers.

   The objective of the project is to assess the economic efficiency of the project for the new production of antitumor drugs in various dosage forms at a Russian pharmaceutical enterprise in St. Petersburg.

   Material and methods. Reports on the state of cancer care to the population of Russia, data on sales of anticancer drugs in the Russian pharmaceutical market, presented by the analytical company DSM Group, official statistical information. The economic efficiency of the investment project was assessed based on the calculation of net present value, profitability index, payback period and internal rate of return.

   Results and discussion. In recent years, the need for the use of anticancer drugs has increased in Russia due to the rise in the incidence of cancer in the population. A project has been developed to create a domestic production of 20 names of antitumor drugs in sterile liquid and solid dosage forms, the implementation of which in St. Petersburg will require investment costs in the amount of 1.16 billion rubles.

   Conclusion. As a result of the assessment, the necessity and economic efficiency of the practical implementation of the project of creating a new domestic production of antitumor drugs in various dosage forms at a Russian pharmaceutical enterprise in the territory of the city of St. Petersburg are substantiated.

1. Federal'nyj proekt ot 14 dekabrja 2018 g. «Bor'ba s onkologicheskimi zabolevaniyami» («Fight against oncological diseases»). Ministerstvo zdravookhraneniya Rossiiskoi Federatsii. URL: https://onco-life.ru / (Accessed: 23. 03. 2024). (In Russ).

2. Farmatsevticheskii rynok Rossii. Itogi 2023 g. : analiticheskii otchet. (The pharmaceutical market of Russia. Results of 2023: analytical report). Moscow: JSC «DSM GROUP», 2024:12. (In Russ).

3. Orlov A.S. Farmatsevticheskii rynok: problemy i perspektivy (Pharmaceutical market: problems and prospects). Novaya apteka. Effektivnoe upravlenie. 2014;(9):12-21. (In Russ).

4. Kaprina A.D., Starinsky V.V., Shakhzadova A.O. Sostoyanie onkologicheskoi pomoshchi naseleniyu Rossii v 2022 godu (The state of oncological care for the population of Russia in 2022). Moskva: MNIOI im. P.A. Gertsena − filial FGBU «NMITs radiologii» Minzdrava Rossii. 2022;(1):1-24. (In Russ).

5. Federal'naya sluzhba gosudarstvennoi statistiki (Federal State Statistics Service). URL: https://rosstat.gov.ru / (Accessed: 11. 03. 2024). (In Russ).

6. Rasporyazhenie Pravitel'stva Sankt-Peterburga ot 28. 06. 2019 N 21-rp (red. ot 30. 10. 2019) «Ob utverzhdenii Regional'noi programmy Sankt-Peterburga «Bor'ba s onkologicheskimi zabolevaniyami» na 2019-2024 gody» (Order of the Government of St. Petersburg dated 06/28/2019 No. 21-rp (ed. dated 30. 10. 2019) «On approval of the Regional Program of St. Petersburg «Fight against oncological diseases» for 2019-2024»). Komitet po zdravookhraneniyu Sankt-Peterburga. URL: https://www.consultant.ru / (Accessed:11. 03. 2024). (In Russ).

7. Petrukhina I.K., Ryazanova T.K., Gladunova E.P., Lazarev A.M., Krivova A.A. Sales of antitumor drugs in the retail segment of the Russian pharmaceutical market. Farmakoekonomika. Modern Pharmacoeconomics and Pharmacoepidemiology. 2023;16(4):619-629. (In Russ.)

8. Moiseenko V. M., Volkov N. M. Spravochnik. Lekarstvennoe lechenie zlokachestvennykh opukholei (Handbook. Medicinal treatment of malignant tumors). St. Petersburg: Center of TOMM. 2014;(1): 53-55. (In Russ).

9. Palagina A.A. Trends in the treatment and prevention of oncological diseases in Russia and the world. Young pharmacy – the potential of the future : A collection of materials of the XIII All-Russian scientific conference of students and postgraduates with international participation, St. Petersburg, 01. 03. 23 – 11. 04. 23 / St. Petersburg State Chemical and Pharmaceutical University. St. Petersburg: SPCPU. 2023;(1): 572– 579. (In Russ).

10. Romanov B.K., Dmitrieva N.B., Zatsepilova T.A. The antitumoral medications. Russian Medical Journal. 2018; 24(3): 146-150.

11. Orlov A.S. Assessment of the level of sales concentration in the framework of the development of strategic decisions in the field of pricing for drugs. Medico-pharmaceutical journal «Pulse». 2022;24(12):61-66. (In Russ).

12. Prognoz dolgosrochnogo sotsial'no-ekonomicheskogo razvitiya Rossiiskoi Federatsii na period do 2030 goda (Forecast of the long-term socio-economic development of the Russian Federation for the period up to 2030). URL: https://www.consultant.ru/document/cons_doc_LAW_144190 / (Accessed: 14. 03. 2024). (In Russ).